- Home
- SYRA vs SBFM Comparison
SYRA vs SBFM Comparison
Compare SYRA & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRA
- SBFM
- Stock Information
- Founded
- SYRA 2020
- SBFM 2006
- Country
- SYRA United States
- SBFM United States
- Employees
- SYRA N/A
- SBFM N/A
- Industry
- SYRA Other Specialty Stores
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- SYRA Industrials
- SBFM Health Care
- Exchange
- SYRA Nasdaq
- SBFM Nasdaq
- Market Cap
- SYRA 4.2M
- SBFM 3.7M
- IPO Year
- SYRA 2023
- SBFM N/A
- Fundamental
- Price
- SYRA $0.36
- SBFM $2.35
- Analyst Decision
- SYRA
- SBFM
- Analyst Count
- SYRA 0
- SBFM 0
- Target Price
- SYRA N/A
- SBFM N/A
- AVG Volume (30 Days)
- SYRA 178.3K
- SBFM 151.4K
- Earning Date
- SYRA 10-29-2024
- SBFM 11-05-2024
- Dividend Yield
- SYRA N/A
- SBFM N/A
- EPS Growth
- SYRA N/A
- SBFM N/A
- EPS
- SYRA N/A
- SBFM N/A
- Revenue
- SYRA $7,741,558.00
- SBFM $32,959,491.00
- Revenue This Year
- SYRA $47.74
- SBFM $86.70
- Revenue Next Year
- SYRA N/A
- SBFM $126.76
- P/E Ratio
- SYRA N/A
- SBFM N/A
- Revenue Growth
- SYRA 35.47
- SBFM 61.94
- 52 Week Low
- SYRA $0.34
- SBFM $2.25
- 52 Week High
- SYRA $8.37
- SBFM $638.00
- Technical
- Relative Strength Index (RSI)
- SYRA 33.92
- SBFM 25.54
- Support Level
- SYRA $0.37
- SBFM $2.58
- Resistance Level
- SYRA $0.44
- SBFM $2.86
- Average True Range (ATR)
- SYRA 0.04
- SBFM 0.17
- MACD
- SYRA 0.00
- SBFM -0.04
- Stochastic Oscillator
- SYRA 3.27
- SBFM 12.67
About SYRA Syra Health Corp.
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.